Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis.
about
Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacyNanomedicine delivers promising treatments for rheumatoid arthritisFabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoidsNano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative DiseasesSeparating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: long-term suppression of arthritis facilitates interval treatmentLiposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis.Niosomes of ascorbic acid and α-tocopherol in the cerebral ischemia-reperfusion model in male ratsIrinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic CancerSynthesis and evaluation of a well-defined HPMA copolymer-dexamethasone conjugate for effective treatment of rheumatoid arthritis.Milatuzumab-conjugated liposomes as targeted dexamethasone carriers for therapeutic delivery in CD74+ B-cell malignancies.Lipid-based nanotherapeutics for siRNA deliveryUsing liposomes to target infection and inflammation induced by foreign body injuries or medical implants.Designing micro- and nano-particles for treating rheumatoid arthritis.The intelligent use of systemic glucocorticoids in rheumatoid arthritis.The use of lipid-based nanocarriers for targeted pain therapies.Drug Trafficking into Macrophages via the Endocytotic Receptor CD163.A Simple and Improved Active Loading Method to Efficiently Encapsulate Staurosporine into Lipid-Based Nanoparticles for Enhanced Therapy of Multidrug Resistant Cancer.Nanotechnology application for pain therapy.Quantitative structure-property relationship modeling of remote liposome loading of drugs.Upcycling drugs for brain-related diseases: a sustainable future for targeted drug delivery.Liposomal nano-drugs based on amphipathic weak acid steroid prodrugs for treatment of inflammatory diseases.Application of liposomes in treatment of rheumatoid arthritis: quo vadis
P2860
Q22000845-F1813279-2C2C-41BB-A272-84BADCBEB64BQ27021438-1DD638CF-43F6-4F99-89DB-79226C297F12Q28477392-21CAA025-8264-4FED-8632-2F48BFA8F5DBQ28546214-7FBDA18D-4314-4033-BAEE-404CC8D8D9CEQ30318833-65D00A88-8D86-4465-BDEE-4A396E68ACCFQ34153033-3485EDCA-30C1-494C-8787-88B49D7CA001Q34177003-CAF46157-E7C6-484A-92E8-D8825096F059Q36852611-3BAE8AB9-F490-4682-BE06-D52A7044DEB2Q36994094-B3855E29-5D5F-48EB-B9C1-F6654D0C6E28Q37221480-8562B4C2-6332-4624-B1B0-9B50B70DBAC5Q37670986-F55B9CBC-62C5-4EAD-B2D9-EFBB263C1AC1Q37790712-A6CC364E-A356-4270-B9A3-41C1D14E4B4CQ37964579-055E9196-976E-4756-A474-46025EC38E20Q38168952-E8414293-8CEA-48A5-952F-6895474C1F3FQ38169707-FAC65D22-5B50-4F02-A10C-7E998D2686FCQ38537751-16D7440E-C80B-4490-8754-F876EFCE771DQ38804342-10103388-3993-4098-BD1B-724B2B4D16FEQ39232325-2A9F271D-D82D-4C85-911E-79B2CEDCF5A7Q42322486-58F6134F-067F-4DE8-878D-7E6341E04A8FQ44809828-CA7E8F32-B4AB-4B97-8E6E-EA806D694204Q47975293-9AD9972D-C549-47F8-B38E-3E1E7465CF0FQ59101195-260B9946-D6FA-49EC-9922-9C2224353AB5
P2860
Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Amphipathic weak acid glucocor ...... treating autoimmune arthritis.
@en
Amphipathic weak acid glucocor ...... treating autoimmune arthritis.
@nl
type
label
Amphipathic weak acid glucocor ...... treating autoimmune arthritis.
@en
Amphipathic weak acid glucocor ...... treating autoimmune arthritis.
@nl
prefLabel
Amphipathic weak acid glucocor ...... treating autoimmune arthritis.
@en
Amphipathic weak acid glucocor ...... treating autoimmune arthritis.
@nl
P2093
P356
P1476
Amphipathic weak acid glucocor ...... treating autoimmune arthritis.
@en
P2093
Maya Broyer
Rina Ulmansky
Simcha Even-Chen
Veronica Wasserman
Yaakov Naparstek
Yechezkel Barenholz
Yuval Avnir
P2860
P304
P356
10.1002/ART.23230
P577
2008-01-01T00:00:00Z